Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.

about

Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity.

P2860

Q55267052-167E31F8-B202-4162-BEA0-B5743B5CC4F7

P2860

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.

Item

http://www.wikidata.org/entity/Q41701253

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.

@en

type

Item

label

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.

@en

prefLabel

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.

@en

P1476

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.

@en

P2093

Alejandra Gomez-Cadena

http://www.w3.org/2001/XMLSchema#string

Alessandro Rambaldi

http://www.w3.org/2001/XMLSchema#string

Amaia Martinez-Usatorre

http://www.w3.org/2001/XMLSchema#string

Andrew N J McKenzie

http://www.w3.org/2001/XMLSchema#string

Antonio Curti

http://www.w3.org/2001/XMLSchema#string

Armando Santoro

http://www.w3.org/2001/XMLSchema#string

Camille Grandclément

http://www.w3.org/2001/XMLSchema#string

Cezmi A Akdis

http://www.w3.org/2001/XMLSchema#string

Cristina Tresoldi

http://www.w3.org/2001/XMLSchema#string

Daniela Taurino

http://www.w3.org/2001/XMLSchema#string

P2860

Transcription factor RORα is critical for nuocyte development

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Development and function of group 2 innate lymphoid cells

Innate lymphoid cells, possible interaction with microbiota

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

Phenotype, development, and biological function of myeloid-derived suppressor cells

Immune checkpoint blockade: a common denominator approach to cancer therapy

Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs

Coordinated regulation of myeloid cells by tumours

Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation

P2888

s41467-017-00678-2

P304

593

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-017-00678-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cristina Papayannidis

Luca Mazzarella

Bérengère Salomé

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091688620

http://www.w3.org/2001/XMLSchema#string

P698

28928446

http://www.w3.org/2001/XMLSchema#string

P932

5605498

http://www.w3.org/2001/XMLSchema#string

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.

about

P2860

P2860

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932